Foley Partner and chair of the Securities, Commodities & Exchange Regulation Practice George Simon was quoted in an article titled “Unorthodox products get a health warning” in the June 28, 2009 issue of Financial Times. Simon discusses a notice issued by the Financial Industry Regulatory Authority (Finra) stating that inverse and leveraged ETFs typically are not suitable for retail investors who plan to hold them for more than one trading session. Simon remarked that the notice from Finra was stark in its language and may spell the end of the sector.
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."